<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01895933</url>
  </required_header>
  <id_info>
    <org_study_id>DMED-SS001</org_study_id>
    <nct_id>NCT01895933</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel</brief_title>
  <official_title>The Aim of This Study is to Evaluate the Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel Made by D Med</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>D.med</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dankook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chungbuk National University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>D.med</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is intended to evaluate the impact, efficacy, and safety of Chitosan
      formulated adhesion inhibitor, SurgiShield when used in the process of wound healing after
      endoscopic sinus surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adhesion Rate</measure>
    <time_frame>at 2 weeks</time_frame>
    <description>Adhesion rate at 2 weeks after ESS(endoscopic sinus surgery)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adhesion Rate</measure>
    <time_frame>at 1 and 4 weeks</time_frame>
    <description>Adhesion rate at 1 and 4 weeks after ESS(endoscopic sinus surgery) Bleeding score at 0,2,4,6,8,10 minutes after ESS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Wound Healing</condition>
  <arm_group>
    <arm_group_label>Active / control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One side has been treated with SurgiShield</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>One side has no intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>5ml surgishield</intervention_name>
    <description>in the case of active, apply solution type adhesion barrier to merocel and pack 5ml of adhesion inhibitor Surgi Shield on the surgical site
merocel in the inflated state maintained for 36~48 hours, remove packing then solution type adhesion inhibitor is to be injected in to the surgical site</description>
    <arm_group_label>Active / control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older than 21 years of age

          -  both side sinusitis

          -  will undergo endoscopic sinus surgery

          -  volunteers with informed consent and signature

        Exclusion Criteria:

          -  suppressed immunity patient

          -  systemic grave condition

          -  pregnant

          -  cancer

          -  severe disease patients

          -  asthma patients

          -  AIDS

          -  cystic fibrosis

          -  ciliary immobility syndrome

          -  neutropenia neutrophil

          -  immunoglobulin deficiency

          -  wound healing immune disease

          -  severe liver disease

          -  severe kidney disease

          -  lymph or blood clotting disorder or patients treated with coagulants

          -  patients taking oral or parenteral glucose for diabetes thrombocytopenia

          -  infectious disease

          -  currently lactating

          -  severe septal deviation

          -  case where there is a severe difference in sinusitis state between sides of nose:
             there is a 3 or more score difference on the Lund-Mackey CT scan scoring system
             PNS(ParaNasalSinus)

          -  shellfish allergy

          -  food allergy

          -  had endoscopic sinus surgery in the past

          -  patient with large sinus polyps

          -  patients who have received treatment for extrasinus complication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chungbook National University Hospital</name>
      <address>
        <city>ChungJu</city>
        <state>ChoongChungBukDo</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dankook University Hospital</name>
      <address>
        <city>ChunAhn</city>
        <state>ChoongChungNamDo</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2013</study_first_submitted>
  <study_first_submitted_qc>July 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2013</study_first_posted>
  <last_update_submitted>July 21, 2013</last_update_submitted>
  <last_update_submitted_qc>July 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Investigational device (chitosan gel)</keyword>
  <keyword>Wound healing</keyword>
  <keyword>Endoscopic sinus surgery</keyword>
  <keyword>SurgiShield</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

